• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

挖掘基因组测序数据以识别与乳腺癌组织病理学相关的基因组特征。

Mining genome sequencing data to identify the genomic features linked to breast cancer histopathology.

作者信息

Ping Zheng, Siegal Gene P, Almeida Jonas S, Schnitt Stuart J, Shen Dejun

机构信息

Department of Pathology, Division of Anatomic Pathology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Department of Pathology, Division of Informatics, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.

出版信息

J Pathol Inform. 2014 Jan 31;5(1):3. doi: 10.4103/2153-3539.126147. eCollection 2014.

DOI:10.4103/2153-3539.126147
PMID:24672738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3952399/
Abstract

BACKGROUND

Genetics and genomics have radically altered our understanding of breast cancer progression. However, the genomic basis of various histopathologic features of breast cancer is not yet well-defined.

MATERIALS AND METHODS

The Cancer Genome Atlas (TCGA) is an international database containing a large collection of human cancer genome sequencing data. cBioPortal is a web tool developed for mining these sequencing data. We performed mining of TCGA sequencing data in an attempt to characterize the genomic features correlated with breast cancer histopathology. We first assessed the quality of the TCGA data using a group of genes with known alterations in various cancers. Both genome-wide gene mutation and copy number changes as well as a group of genes with a high frequency of genetic changes were then correlated with various histopathologic features of invasive breast cancer.

RESULTS

Validation of TCGA data using a group of genes with known alterations in breast cancer suggests that the TCGA has accurately documented the genomic abnormalities of multiple malignancies. Further analysis of TCGA breast cancer sequencing data shows that accumulation of specific genomic defects is associated with higher tumor grade, larger tumor size and receptor negativity. Distinct groups of genomic changes were found to be associated with the different grades of invasive ductal carcinoma. The mutator role of the TP53 gene was validated by genomic sequencing data of invasive breast cancer and TP53 mutation was found to play a critical role in defining high tumor grade.

CONCLUSIONS

Data mining of the TCGA genome sequencing data is an innovative and reliable method to help characterize the genomic abnormalities associated with histopathologic features of invasive breast cancer.

摘要

背景

遗传学和基因组学已彻底改变了我们对乳腺癌进展的理解。然而,乳腺癌各种组织病理学特征的基因组基础尚未明确界定。

材料与方法

癌症基因组图谱(TCGA)是一个国际数据库,包含大量人类癌症基因组测序数据。cBioPortal是一个为挖掘这些测序数据而开发的网络工具。我们对TCGA测序数据进行挖掘,试图描绘与乳腺癌组织病理学相关的基因组特征。我们首先使用一组在各种癌症中具有已知改变的基因评估TCGA数据的质量。然后将全基因组基因突变和拷贝数变化以及一组具有高频率基因变化的基因与浸润性乳腺癌的各种组织病理学特征相关联。

结果

使用一组在乳腺癌中具有已知改变的基因对TCGA数据进行验证表明,TCGA已准确记录了多种恶性肿瘤的基因组异常。对TCGA乳腺癌测序数据的进一步分析表明,特定基因组缺陷的积累与更高的肿瘤分级、更大的肿瘤大小和受体阴性相关。发现不同组的基因组变化与不同分级的浸润性导管癌相关。TP53基因的突变作用通过浸润性乳腺癌的基因组测序数据得到验证,并且发现TP53突变在定义高肿瘤分级中起关键作用。

结论

对TCGA基因组测序数据进行数据挖掘是一种创新且可靠的方法,有助于描绘与浸润性乳腺癌组织病理学特征相关的基因组异常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/aa5fd4c96752/JPI-5-3-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/dae5819975f1/JPI-5-3-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/859d1ab3842b/JPI-5-3-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/dfd16536ecb0/JPI-5-3-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/7653690ae098/JPI-5-3-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/3edcf0149f5c/JPI-5-3-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/0fd7ba97be9d/JPI-5-3-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/0b9f39d5e000/JPI-5-3-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/9c8e43845e7c/JPI-5-3-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/361c361eb0fd/JPI-5-3-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/aa5fd4c96752/JPI-5-3-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/dae5819975f1/JPI-5-3-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/859d1ab3842b/JPI-5-3-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/dfd16536ecb0/JPI-5-3-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/7653690ae098/JPI-5-3-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/3edcf0149f5c/JPI-5-3-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/0fd7ba97be9d/JPI-5-3-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/0b9f39d5e000/JPI-5-3-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/9c8e43845e7c/JPI-5-3-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/361c361eb0fd/JPI-5-3-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a4/3952399/aa5fd4c96752/JPI-5-3-g011.jpg

相似文献

1
Mining genome sequencing data to identify the genomic features linked to breast cancer histopathology.挖掘基因组测序数据以识别与乳腺癌组织病理学相关的基因组特征。
J Pathol Inform. 2014 Jan 31;5(1):3. doi: 10.4103/2153-3539.126147. eCollection 2014.
2
The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical-genomic driver associations.癌症基因组图谱临床浏览器:用于识别临床基因组驱动因素关联的网络和移动界面。
Genome Med. 2015 Oct 27;7:112. doi: 10.1186/s13073-015-0226-3.
3
Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.中国乳腺肿瘤中频繁突变的癌症基因特征:中国人群与癌症基因组图谱(TCGA)队列的比较
Ann Transl Med. 2019 Apr;7(8):179. doi: 10.21037/atm.2019.04.23.
4
A microscopic landscape of the invasive breast cancer genome.浸润性乳腺癌基因组的微观图景。
Sci Rep. 2016 Jun 10;6:27545. doi: 10.1038/srep27545.
5
ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.ERBB2突变与CDH1改变的乳腺浸润性小叶癌患者的预后较差相关。
Oncotarget. 2016 Dec 6;7(49):80655-80663. doi: 10.18632/oncotarget.13019.
6
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.RB1 和 TP53 共突变与膀胱癌对免疫检查点抑制剂反应的基因组生物标志物密切相关。
BMC Cancer. 2021 Apr 20;21(1):432. doi: 10.1186/s12885-021-08078-y.
7
The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas.泌尿生殖系统恶性肿瘤全基因组改变与病理特征全景:癌症基因组图谱分析。
Eur Urol Focus. 2017 Dec;3(6):584-589. doi: 10.1016/j.euf.2017.01.007. Epub 2017 Feb 8.
8
Data mining The Cancer Genome Atlas in the era of precision cancer medicine.在精准癌症医学时代挖掘癌症基因组图谱数据。
Swiss Med Wkly. 2015 Sep 16;145:w14183. doi: 10.4414/smw.2015.14183. eCollection 2015.
9
Exomes of Ductal Luminal Breast Cancer Patients from Southwest Colombia: Gene Mutational Profile and Related Expression Alterations.哥伦比亚西南部乳腺导管内癌患者的外显子组:基因突变谱及相关表达改变。
Biomolecules. 2020 Apr 30;10(5):698. doi: 10.3390/biom10050698.
10
Distinct signatures of codon and codon pair usage in 32 primary tumor types in the novel database CancerCoCoPUTs for cancer-specific codon usage.在用于癌症特异性密码子使用的新型数据库 CancerCoCoPUTs 中,32 种原发性肿瘤类型中密码子和密码子对使用的独特特征。
Genome Med. 2021 Jul 28;13(1):122. doi: 10.1186/s13073-021-00935-6.

引用本文的文献

1
Association of ATP-binding cassette transporter genomic alterations and expressions with patient survival in breast and prostate cancer.ATP结合盒转运体基因改变及表达与乳腺癌和前列腺癌患者生存的相关性
Physiol Rep. 2025 Jul;13(13):e70460. doi: 10.14814/phy2.70460.
2
Genome analysis uncovers an inverse correlation between alterations in P21-activated kinases and patient survival across multiple cancer types.基因组分析揭示了多种癌症类型中P21激活激酶的改变与患者生存率之间的负相关关系。
Physiol Rep. 2025 Jan;13(1):e70192. doi: 10.14814/phy2.70192.
3
Long-Lasting Complete Remission in a Patient With Metastatic Metaplastic Breast Cancer Treated With Immune Checkpoint Inhibitor and Chemotherapy: A Case Report and a Review of the Literature.

本文引用的文献

1
Molecular and protein markers for clinical decision making in breast cancer: today and tomorrow.乳腺癌临床决策的分子和蛋白质标志物:今天和明天。
Cancer Treat Rev. 2014 Apr;40(3):434-44. doi: 10.1016/j.ctrv.2013.09.014. Epub 2013 Sep 29.
2
A self-updating road map of The Cancer Genome Atlas.癌症基因组图谱的自更新路线图。
Bioinformatics. 2013 May 15;29(10):1333-40. doi: 10.1093/bioinformatics/btt141. Epub 2013 Apr 17.
3
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.利用 cBioPortal 进行复杂癌症基因组学和临床特征的综合分析
免疫检查点抑制剂联合化疗治疗转移性化生性乳腺癌患者的长期完全缓解:病例报告及文献综述
Cureus. 2024 Feb 1;16(2):e53419. doi: 10.7759/cureus.53419. eCollection 2024 Feb.
4
Identification and evaluation of a risk model predicting the prognosis of breast cancer based on characteristic signatures.基于特征标记预测乳腺癌预后的风险模型的识别与评估
Transl Cancer Res. 2023 Jun 30;12(6):1441-1451. doi: 10.21037/tcr-22-2444. Epub 2023 Jun 12.
5
Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastoma.基于血液的 T 细胞受体抗病毒 CDR3 与神经母细胞瘤患者总生存率降低相关。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12047-12056. doi: 10.1007/s00432-023-05059-5. Epub 2023 Jul 8.
6
Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins.成年小鼠乳腺导管上皮中 Brca1 和 Trp53 的缺失导致激素受体阳性或激素受体阴性肿瘤的发展,这取决于 Rb 家族蛋白的失活。
Breast Cancer Res. 2022 Nov 4;24(1):75. doi: 10.1186/s13058-022-01566-4.
7
Expression profile analysis identifies IER3 to predict overall survival and promote lymph node metastasis in tongue cancer.表达谱分析确定IER3可预测舌癌的总生存期并促进淋巴结转移。
Cancer Cell Int. 2019 Nov 21;19:307. doi: 10.1186/s12935-019-1028-2. eCollection 2019.
8
The Role of ZNF143 in Breast Cancer Cell Survival Through the NAD(P)H Quinone Dehydrogenase 1⁻p53⁻Beclin1 Axis Under Metabolic Stress.ZNF143 在代谢应激下通过 NAD(P)H 醌氧化还原酶 1⁻p53⁻Beclin1 轴促进乳腺癌细胞存活中的作用。
Cells. 2019 Mar 30;8(4):296. doi: 10.3390/cells8040296.
9
Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.从低级别胶质瘤外显子组文件中恢复 T 细胞受体 V(D)J 重组读取与降低的存活率和较高的癌症分级相关。
J Neurooncol. 2018 Dec;140(3):697-704. doi: 10.1007/s11060-018-03001-1. Epub 2018 Oct 31.
10
Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival.从胰腺癌外显子文件中恢复免疫球蛋白VJ重组与生存率降低密切相关。
Cancer Microenviron. 2018 Jun;11(1):51-59. doi: 10.1007/s12307-018-0205-5. Epub 2018 Feb 5.
Sci Signal. 2013 Apr 2;6(269):pl1. doi: 10.1126/scisignal.2004088.
4
Cancer genome landscapes.肿瘤基因组图谱。
Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122.
5
Digital imaging in pathology: whole-slide imaging and beyond.病理学中的数字成像:全切片成像及其他。
Annu Rev Pathol. 2013 Jan 24;8:331-59. doi: 10.1146/annurev-pathol-011811-120902. Epub 2012 Nov 15.
6
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling.定量分析乳腺肿瘤中的细胞异质性可补充基因组分析。
Sci Transl Med. 2012 Oct 24;4(157):157ra143. doi: 10.1126/scitranslmed.3004330.
7
Comprehensive molecular portraits of human breast tumours.人类乳腺肿瘤的全面分子特征图谱。
Nature. 2012 Oct 4;490(7418):61-70. doi: 10.1038/nature11412. Epub 2012 Sep 23.
8
Statistical challenges associated with detecting copy number variations with next-generation sequencing.与下一代测序检测拷贝数变异相关的统计挑战。
Bioinformatics. 2012 Nov 1;28(21):2711-8. doi: 10.1093/bioinformatics/bts535. Epub 2012 Aug 31.
9
The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development.雌激素反应性 Agr2 基因调节乳腺上皮细胞增殖,并促进小叶腺泡发育。
Dev Biol. 2012 Sep 15;369(2):249-60. doi: 10.1016/j.ydbio.2012.06.030. Epub 2012 Jul 20.
10
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.cBio 癌症基因组学门户:一个用于探索多维癌症基因组学数据的开放平台。
Cancer Discov. 2012 May;2(5):401-4. doi: 10.1158/2159-8290.CD-12-0095.